loading
전일 마감가:
$3.74
열려 있는:
$3.74
하루 거래량:
447.73K
Relative Volume:
1.05
시가총액:
$333.76M
수익:
$351.37M
순이익/손실:
$-174.01M
주가수익비율:
-1.8841
EPS:
-2.07
순현금흐름:
$-126.94M
1주 성능:
+16.07%
1개월 성능:
+12.39%
6개월 성능:
+23.42%
1년 성능:
+0.00%
1일 변동 폭
Value
$3.71
$3.9177
1주일 범위
Value
$3.39
$3.9177
52주 변동 폭
Value
$2.455
$4.145

Atea Pharmaceuticals Inc Stock (AVIR) Company Profile

Name
명칭
Atea Pharmaceuticals Inc
Name
전화
857-204-8109
Name
주소
225 FRANKLIN STREET, BOSTON
Name
직원
56
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
AVIR's Discussions on Twitter

AVIR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AVIR
Atea Pharmaceuticals Inc
3.90 320.07M 351.37M -174.01M -126.94M -2.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-13 업그레이드 Morgan Stanley Underweight → Equal-Weight
2023-08-10 다운그레이드 JP Morgan Neutral → Underweight
2022-01-06 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2021-11-18 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-10-20 다운그레이드 JP Morgan Overweight → Neutral
2021-10-05 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-11-25 개시 Evercore ISI Outperform
2020-11-24 개시 JP Morgan Overweight
2020-11-24 개시 Morgan Stanley Overweight
2020-11-24 개시 William Blair Outperform
모두보기

Atea Pharmaceuticals Inc 주식(AVIR)의 최신 뉴스

pulisher
Jul 25, 2025

What drives Atea Pharmaceuticals Inc. stock priceExceptional earning trajectories - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Atea Pharmaceuticals Inc. stockSuperior risk-adjusted returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What risks could impact Atea Pharmaceuticals Inc. stock performanceHigh-yield capital appreciation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

3 Promising Penny Stocks With A Market Cap Of At Least $200M - simplywall.st

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Atea Pharmaceuticals Inc. stock outlookHigh-velocity gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Will Atea Pharmaceuticals Inc. stock benefit from interest rate changesExceptional profit margins - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Insiders Placed Bullish Bets Worth US$5.40m - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Atea Pharmaceuticals Inc. a good long term investmentPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Atea Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atea Pharmaceuticals Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Atea Pharmaceuticals Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jun 29, 2025

Atea Pharmaceuticals announces continued advancement of global Phase 3 HCV program - European AIDS Treatment Group

Jun 29, 2025
pulisher
Jun 26, 2025

Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing - Bain Capital

Jun 26, 2025
pulisher
Jun 24, 2025

New Hepatitis C Treatment Could Slash Therapy Time to 8 Weeks as Global Phase 3 Trial Advances - Stock Titan

Jun 24, 2025
pulisher
Jun 20, 2025

Atea Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 17, 2025

Here's Why We're Not At All Concerned With Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Situation - Yahoo Finance

Jun 17, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Boosts Stock Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Invests $75,000 in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 14, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Buys 35,053 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares Sold by Two Sigma Investments LP - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Jane Street Group LLC Decreases Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Public Employees Retirement System of Ohio Trims Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 06, 2025

Atea Pharmaceuticals Inc (AVIR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Atea Pharmaceuticals Inc 주식 (AVIR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
BERGER FRANKLIN M
Director
Jun 20 '25
Option Exercise
0.00
29,600
0
506,497
Duncan Barbara Gayle
Director
Jun 20 '25
Option Exercise
0.00
29,600
0
62,750
Polsky Bruce
Director
Jun 20 '25
Option Exercise
0.00
29,600
0
95,206
Adams Jerome M.
Director
Jun 20 '25
Option Exercise
0.00
29,600
0
62,750
Lucidi Bruno
Director
Jun 20 '25
Option Exercise
0.00
29,600
0
112,750
BERGER FRANKLIN M
Director
Dec 10 '24
Sale
2.85
359,606
1,023,475
451,897
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):